National Drug Stockout Risks and the Global Fund Disbursement Process for Procurement

Despite substantial financial aid from international donors for procurement of health products, stockouts of life-saving drugs related to prevalent infectious diseases are still widespread in Africa. Rigorous research to understand the underlying causes of these stockouts is lacking. To this end, we study the relationship between The Global Fund to Fight AIDS, Tuberculosis and Malaria and its grant recipients. Specifically, we leverage historical fund disbursement and drug procurement data from 2002 to 2013 to build a discrete-event simulation model predicting the joint impact of procurement and grant disbursement processes on national drug availability for the Global Fund's recipient countries in Africa. This model is validated against cumulative stockout levels inferred from historical grant implementation lengths, and used to evaluate potential high-level modifications in the disbursement or procurement process. Results show the existence of significant intrinsic stockout risks in most African countries, with particularly high levels in East Africa, due to the unpredictability of fund disbursements and the frequency of grant performance monitoring performed by the Global Fund. Interventions shifting some fund disbursements upfront to protect against disbursement timing uncertainty are predicted to be more effective than others that include regional buffer stocks and bridge financing.

[1]  Young-Eun Kim,et al.  Why They Are Different: Based on the Burden of Disease Research of WHO and Institute for Health Metrics and Evaluation , 2018, BioMed research international.

[2]  C. Halberstadt What We Are. , 2017, JAMA.

[3]  Ananth V. Iyer,et al.  Disentangling the efficiency drivers in country‐level global health programs: An empirical study , 2016 .

[4]  Jayashankar M. Swaminathan,et al.  Inventory Management in Humanitarian Operations: Impact of Amount, Schedule, and Uncertainty in Funding , 2014, Manuf. Serv. Oper. Manag..

[5]  Terry A. Taylor,et al.  Subsidizing the Distribution Channel: Donor Funding to Improve the Availability of Malaria Drugs , 2014, Manag. Sci..

[6]  D. Simchi-Levi,et al.  Dynamic inventory control with limited capital and short‐term financing , 2014 .

[7]  Rachel Silverman,et al.  Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12. , 2013, The Lancet. Global health.

[8]  Santiago Kraiselburd,et al.  Supply Chains and Global Health: An Imperative for Bringing Operations Management Scholarship into Action , 2013 .

[9]  R. Atun,et al.  Innovative financing for health: what is truly innovative? , 2012, The Lancet.

[10]  R. Shretta,et al.  Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up , 2012, Malaria Journal.

[11]  D. Ansong,et al.  Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data , 2012, The Lancet.

[12]  James W. Taylor,et al.  Density Forecasting of Intraday Call Center Arrivals Using Models Based on Exponential Smoothing , 2012, Manag. Sci..

[13]  N. Hawkes Gains in malaria control will be lost if funding stalls , 2011, BMJ : British Medical Journal.

[14]  Neff Walker,et al.  Mathematical models in the evaluation of health programmes , 2011, The Lancet.

[15]  K. Freedberg,et al.  Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire , 2010, PloS one.

[16]  Brian Tomlin,et al.  To wait or not to wait: Optimal ordering under lead time uncertainty and forecast updating , 2009 .

[17]  E. Veitch,et al.  Time for a “Third Wave” of Malaria Activism to Tackle the Drug Stock-out Crisis , 2009, PLoS medicine.

[18]  Sylvain Arlot,et al.  A survey of cross-validation procedures for model selection , 2009, 0907.4728.

[19]  Tim Evans,et al.  An assessment of interactions between global health initiatives and country health systems , 2009, The Lancet.

[20]  X. Chao,et al.  Dynamic inventory management with cash flow constraints , 2008 .

[21]  Megan E O'Brien,et al.  Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies , 2008, Malaria Journal.

[22]  D. Sridhar,et al.  Misfinancing global health: a case for transparency in disbursements and decision making , 2008, The Lancet.

[23]  E. Raaij,et al.  Performance outcomes and success factors of vendor managed inventory (VMI) , 2008 .

[24]  J. Kaufman,et al.  Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries? , 2008, Globalization and health.

[25]  A. Glassman,et al.  Smooth and Predictable Aid for Health: A Role for Innovative Financing? , 2008 .

[26]  Jan Walliser,et al.  Predictability of Aid: Do Fickle Donors Undermine Aid Effectiveness? , 2008 .

[27]  Prashant Yadav,et al.  Demand Forecasting for Essential Medical Technologies , 2008, American Journal of Law & Medicine.

[28]  Jian Li,et al.  Flexible Backup Supply and the Management of Lead‐Time Uncertainty , 2008 .

[29]  S. Radelet,et al.  Global Fund grant programmes: an analysis of evaluation scores , 2007, The Lancet.

[30]  C. Murray,et al.  Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation , 2006, The Lancet.

[31]  John A. Buzacott,et al.  Inventory Management with Asset-Based Financing , 2004, Manag. Sci..

[32]  F. Ssengooba,et al.  The Global Fund: managing great expectations , 2004, The Lancet.

[33]  Jing-Sheng Song The Effect of Leadtime Uncertainty in a Simple Stochastic Inventory Model , 1994 .

[34]  Public Distribution of Essential Medicines in Zambia : Heuristics , Dataset , and Validated Simulation Model February 21 , 2017 , 2017 .

[35]  Georgia Perakis,et al.  On the Effectiveness of Uniform Subsidies in Increasing Market Consumption , 2017, Manag. Sci..

[36]  Cisr Journal United Nations Development Fund for Women , 2015 .

[37]  Jing-Sheng Song,et al.  The Effect of Lead Time and Demand Uncertainties in (r, q) Inventory Systems , 2010, Oper. Res..

[38]  M. Zaffran,et al.  Ensuring Supplies of Appropriate Drugs and Vaccines , 2006 .

[39]  Weltgesundheitsorganisation World malaria report , 2005 .